Insights

Type

Select all that apply

Topic

Select all that apply

icons/content-types/infographic infographic

We offer a robust portfolio of market-leading APIs and world-class capabilities in niche and high-barrier-to-entry technologies.

icons/content-types/white paper white paper

The COVID-19 pandemic has brought the global interdependency of pharmaceutical supply chains into sharp focus, exposing weak links and re-igniting discussions around the value of reshoring production. The U.S. Food and Drug Administration (FDA) repor...

icons/content-types/article article

CDMOs that routinely handle highly potent compounds must raise the bar for containment, safety, and industrial hygiene. Diverse capabilities across chemistries, purification technologies, and analytical techniques — combined with the ability to sup...

icons/content-types/article article

Xtalks spoke with Dr. Steef Boerrigter, a senior research scientist at AMRI and an expert at materials science. He has extensive experience with experimental screening technologies for polymorphs, salts and cocrystals and has developed computational...

icons/content-types/video webinar

AMRI offers more than 240 high-quality, competitively priced APIs and intermediates, including generics, that cover a variety of therapeutic areas. Take a look at our recently filed DMFs.

icons/content-types/video webinar

Oftentimes, the HPAPI sphere places the spotlight on manufacturing due to the containment challenges on large scale however; handling and containment strategies are also relevant in manufacture support roles such as chemical development, analytical...

icons/content-types/article article

A panel of experts share their views on some of the critical issues facing the pharmaceutical industry in regards to API sourcing, new API technical services or manufacturing technologies, guidance on choosing a supplier for API research/development...

icons/content-types/video webinar

Are you looking for the right contract development and manufacturing organization (CDMO) to develop and manufacture your high potency active pharmaceutical ingredients (HPAPIs)? Or have you been unsure about the CDMO you’re currently working with...

icons/utility/left caret 1 icons/utility/right caret